| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Virology, Royal Postgraduate Medical School, Du Cane Road, London W12 0NN, U.K.
Epstein-Barr virus (EBV) has the capacity to immortalize a subpopulation of resting B lymphocytes. Lymphoblastoid cell lines (LCL) established in this way carry the latent EBV genome as multiple copies of an extrachromasomal episome. Viral gene expression in LCLs is highly restricted; products identified correspond to a membrane protein (latent membrane protein; LMP), a nuclear antigen complex (Epstein-Barr nuclear antigens; EBNAs 1 to 6), two small RNA species (EBERs 1 and 2) and RNA species thought to encode a second membrane-associated polypeptide designated terminal protein (TP). Here we have investigated the temporal sequence of expression of the characterized ‘latent’ proteins during the initiation of immortalization when resting B cells are stimulated to enter and traverse the cell cycle. The analysis has been carried out on prolymphocytic leukaemia cells infected in vitro with either the immortalizing B95-8 strain of virus or the non-immortalizing P3HR1 strain. The results reveal that following B95-8 infection, a sequence of EBV expression is initiated within approximately 8 h with the synthesis of detectable levels of EBNA 2 shortly followed by EBNAs 1, 3, 4, 5 and 6. There is then a delay of approximately 40 h until the expression of LMP completes the latent pattern of proteins found in LCLs. P3HR1 infection, however, produces only transient expression of some EBNA species in a small percentage of cells after approximately 48 h. These observations suggest the failure of P3HR1 virus to immortalize may not be due solely to the absence of EBNA 2 expression and that cellular and/or virus-mediated events occur after EBNA synthesis which then facilitate efficient LMP expression and immortalization.
Keywords: EBV, latent gene expression, immortalization
Received 11 November 1988;
accepted 3 March 1989.
This article has been cited by other articles:
|
|
 |
|
  P. D. Ling, J. Tan, J. Sewatanon, and R. Peng Murine Gammaherpesvirus 68 Open Reading Frame 75c Tegument Protein Induces the Degradation of PML and Is Essential for Production of Infectious Virus J. Virol., August 15, 2008; 82(16): 8000 - 8012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Binyamin, R. K. Alpaugh, T. L. Hughes, C. T. Lutz, K. S. Campbell, and L. M. Weiner Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy J. Immunol., May 1, 2008; 180(9): 6392 - 6401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wen, D. Iwakiri, K. Yamamoto, S. Maruo, T. Kanda, and K. Takada Epstein-Barr Virus BZLF1 Gene, a Switch from Latency to Lytic Infection, Is Expressed as an Immediate-Early Gene after Primary Infection of B Lymphocytes J. Virol., January 15, 2007; 81(2): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mancao, M. Altmann, B. Jungnickel, and W. Hammerschmidt Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus Blood, December 15, 2005; 106(13): 4339 - 4344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shannon-Lowe, G. Baldwin, R. Feederle, A. Bell, A. Rickinson, and H.-J. Delecluse Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth J. Gen. Virol., November 1, 2005; 86(11): 3009 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sutkowski, G. Chen, G. Calderon, and B. T. Huber Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen J. Virol., July 15, 2004; 78(14): 7852 - 7860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Thompson and R. Kurzrock Epstein-Barr Virus and Cancer Clin. Cancer Res., February 1, 2004; 10(3): 803 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Sisk, C. R. Bradford, T. E. Carey, A. Paulino, and E. Robertson Epstein-Barr Virus Detected in a Head and Neck Squamous Cell Carcinoma Cell Line Derived From an Immunocompromised Patient Arch Otolaryngol Head Neck Surg, October 1, 2003; 129(10): 1115 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Borestrom, H. Zetterberg, K. Liff, and L. Rymo Functional Interaction of Nuclear Factor Y and Sp1 Is Required for Activation of the Epstein-Barr Virus C Promoter J. Virol., December 20, 2002; 77(2): 821 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cooper, E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth J. Virol., December 20, 2002; 77(2): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Omiya, C. Buteau, H. Kobayashi, C. V. Paya, and E. Celis Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope J. Immunol., August 15, 2002; 169(4): 2172 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Subramanian and E. S. Robertson The Metastatic Suppressor Nm23-H1 Interacts with EBNA3C at Sequences Located between the Glutamine- and Proline-Rich Domains and Can Cooperate in Activation of Transcription J. Virol., July 29, 2002; 76(17): 8702 - 8709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nilsson, H. Zetterberg, Y. C. Wang, and L. Rymo Promoter-Proximal Regulatory Elements Involved in oriP-EBNA1-Independent and -Dependent Activation of the Epstein-Barr Virus C Promoter in B-Lymphoid Cell Lines J. Virol., July 1, 2001; 75(13): 5796 - 5811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gordadze, R. Peng, J. Tan, G. Liu, R. Sutton, B. Kempkes, G. W. Bornkamm, and P. D. Ling Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr Virus J. Virol., July 1, 2001; 75(13): 5899 - 5912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Joseph, G. J. Babcock, and D. A. Thorley-Lawson Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils J. Virol., November 1, 2000; 74(21): 9964 - 9971. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Joseph, G. J. Babcock, and D. A. Thorley-Lawson EBV Persistence Involves Strict Selection of Latently Infected B Cells J. Immunol., September 15, 2000; 165(6): 2975 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Radkov, R. Touitou, A. Brehm, M. Rowe, M. West, T. Kouzarides, and M. J. Allday Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription J. Virol., July 1, 1999; 73(7): 5688 - 5697. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Fuentes-Panana, S. Swaminathan, and P. D. Ling Transcriptional Activation Signals Found in the Epstein-Barr Virus (EBV) Latency C Promoter Are Conserved in the Latency C Promoter Sequences from Baboon and Rhesus Monkey EBV-Like Lymphocryptoviruses (Cercopithicine Herpesviruses 12 and 15) J. Virol., January 1, 1999; 73(1): 826 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Fuentes-Panana and P. D. Ling Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation J. Virol., January 1, 1998; 72(1): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sugano, W. Chen, M. L. Roberts, and N. R. Cooper Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-kappa B Induction J. Exp. Med., August 29, 1997; 186(5): 731 - 737. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
